NanoRepro AG (XTER:NN6) Operating Margin %: -34.85% (As of Jun. 2025)


XTER:NN6 NanoRepro AG XTER:NN6
60 GF Score
Price €2.08
GF Value €1.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NanoRepro AG Operating Margin %?

NanoRepro AG XTER:NN6 60 Operating Margin % is -34.85% as of Jun. 2025. GuruFocus rates XTER:NN6 with a GF Score™ of 60/100 and a GF Value™ of €1.01 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, NanoRepro AG ranks worse than 75% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. NanoRepro AG's Operating Income for the six months ended in Jun. 2025 was €-0.90 Mil. NanoRepro AG's Revenue for the six months ended in Jun. 2025 was €2.57 Mil. Therefore, NanoRepro AG's Operating Margin % for the quarter that ended in Jun. 2025 was -34.85%.

The historical rank and industry rank for NanoRepro AG's Operating Margin % or its related term are showing as below:

XTER:NN6' s Operating Margin % Range Over the Past 10 Years
Min: -220.45   Med: -53.39   Max: 27.62
Current: -39.12


XTER:NN6's Operating Margin % is ranked worse than
75% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs XTER:NN6: -39.12

NanoRepro AG's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

NanoRepro AG's Operating Income for the six months ended in Jun. 2025 was €-0.90 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2025 was €-2.10 Mil.


NanoRepro AG  (XTER:NN6) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


NanoRepro AG Operating Margin % Related Terms


NanoRepro AG Operating Margin % Historical Data

* Premium members only.

The historical data trend for NanoRepro AG's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Operating Margin % Chart

NanoRepro AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.62 24.28 13.98 -136.80 -74.23

NanoRepro AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -159.20 -120.00 -120.83 -43.07 -34.85

XTER:NN6 vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, NanoRepro AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoRepro AG Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's Operating Margin % distribution charts can be found below:

* The bar in red indicates where NanoRepro AG's Operating Margin % falls into.


XTER:NN6
60GF Score
NanoRepro AG XTER:NN6
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NanoRepro AG Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

NanoRepro AG's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-3.45 / 4.648
=-74.23 %

NanoRepro AG's Operating Margin % for the quarter that ended in Jun. 2025 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2025 ) / Revenue (Q: Jun. 2025 )
=-0.896 / 2.571
=-34.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -34.85% mean?
NanoRepro AG (XTER:NN6) has a Operating Margin % of -34.85% as of Jun. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on NanoRepro AG and its competitors. According to the industry distribution chart, NanoRepro AG ranks #153 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 75%.
Is NanoRepro AG's Operating Margin % too high?
NanoRepro AG's current Operating Margin % is -34.85%. Based on the distribution chart, NanoRepro AG ranks #153 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, NanoRepro AG has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, NanoRepro AG ranks #153 out of 204 companies for Operating Margin %. This places NanoRepro AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on NanoRepro AG and its competitors. NanoRepro AG's current Operating Margin % is -34.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (XTER:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.01, compared to a current price of €2.08 — trading 105.9% above its estimated fair value. The current Operating Margin % is -34.85%. NanoRepro AG's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For NanoRepro AG (XTER:NN6), the current Operating Margin % is -34.85% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NanoRepro AG (XTER:NN6) Overvalued in 2026?

Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued. The current stock price of €2.08 is trading 105.9% above its estimated GF Value™ of €1.01. GuruFocus considers NanoRepro AG to be Significantly Overvalued.

Key valuation signals for XTER:NN6:

  • Operating Margin %: -34.85%
  • GF Value™: €1.01 vs. price of €2.08 (105.9% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the XTER:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NanoRepro AG Business Description

Address Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
60GF Score

Get the complete analysis for XTER:NN6

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.08
Price
€1.01
GF Value